We present a case of a 46-year-old patient with an HCV-associated, multilocular hepatocellular carcinoma. Therapy with Sorafenib was discontinued as a result of serious side

Endoscopic treatment for early carcinoma in the gastrointestinal tract has in the meantime become evidence-based and has been incorporated into national and international guidelines

Considerable debate is currently taking place among therapeutic endoscopists regarding the best method of resecting early carcinomas, particularly in the upper gastrointestinal tract — whereas